Exact Mass: 333.1688

Exact Mass Matches: 333.1688

Found 126 metabolites which its exact mass value is equals to given mass value 333.1688, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tebufenpyrad

1H-Pyrazole-5-carboxamide, 4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-

C18H24ClN3O (333.1608)


CONFIDENCE standard compound; INTERNAL_ID 1210; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10181; ORIGINAL_PRECURSOR_SCAN_NO 10180 CONFIDENCE standard compound; INTERNAL_ID 1210; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10149; ORIGINAL_PRECURSOR_SCAN_NO 10147 CONFIDENCE standard compound; INTERNAL_ID 1210; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10181; ORIGINAL_PRECURSOR_SCAN_NO 10178 CONFIDENCE standard compound; INTERNAL_ID 1210; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10099; ORIGINAL_PRECURSOR_SCAN_NO 10097 CONFIDENCE standard compound; INTERNAL_ID 1210; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10204; ORIGINAL_PRECURSOR_SCAN_NO 10202 CONFIDENCE standard compound; INTERNAL_ID 1210; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10140; ORIGINAL_PRECURSOR_SCAN_NO 10138

   

Primidolol

Primidolol

C17H23N3O4 (333.1688)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist Same as: D02389

   

2-(4-methoxyphenyl)-1-phenyl-1-(2-pyridinyl)-2-butanol

(alphaS,betaS)-alpha-Ethyl-alpha-(4-methoxyphenyl)-beta-phenyl-2-pyridineethanol

C22H23NO2 (333.1729)


   

Ipconazole

Pesticide6_Ipconazole Isomer 1*_C18H24ClN3O_2-(4-Chlorobenzyl)-5-isopropyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol

C18H24ClN3O (333.1608)


CONFIDENCE standard compound; INTERNAL_ID 911; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10110; ORIGINAL_PRECURSOR_SCAN_NO 10108 CONFIDENCE standard compound; INTERNAL_ID 911; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10152; ORIGINAL_PRECURSOR_SCAN_NO 10150 CONFIDENCE standard compound; INTERNAL_ID 911; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10122; ORIGINAL_PRECURSOR_SCAN_NO 10120 CONFIDENCE standard compound; INTERNAL_ID 911; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10149; ORIGINAL_PRECURSOR_SCAN_NO 10147 CONFIDENCE standard compound; INTERNAL_ID 911; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10154; ORIGINAL_PRECURSOR_SCAN_NO 10152 CONFIDENCE standard compound; INTERNAL_ID 911; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10099; ORIGINAL_PRECURSOR_SCAN_NO 10097

   

4-Hydroxyoctanedioylcarnitine

3-[(7-Carboxy-4-hydroxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C15H27NO7 (333.1787)


4-hydroxyoctanedioylcarnitine is an acylcarnitine. More specifically, it is an 4-hydroxyoctanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-hydroxyoctanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-hydroxyoctanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Hydroxyoctanedioylcarnitine

3-[(7-carboxy-3-hydroxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H27NO7 (333.1787)


3-hydroxyoctanedioylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxyoctanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-hydroxyoctanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxyoctanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-(2-Hydroxyethoxy)-6-oxohexanoylcarnitine

3-{[6-(2-hydroxyethoxy)-6-oxohexanoyl]oxy}-4-(trimethylazaniumyl)butanoate

C15H27NO7 (333.1787)


6-(2-hydroxyethoxy)-6-oxohexanoylcarnitine is an acylcarnitine. More specifically, it is an 6-(2-hydroxyethoxy)-6-oxohexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-(2-hydroxyethoxy)-6-oxohexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-(2-hydroxyethoxy)-6-oxohexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

CH-223191

1-Methyl-N-{2-methyl-4-[2-(2-methylphenyl)diazen-1-yl]phenyl}-1H-pyrazole-5-carboximidate

C19H19N5O (333.159)


   

Oryzamutaic acid B

Oryzamutaic acid B

C17H23N3O4 (333.1688)


   

Oryzamutaic acid C

Oryzamutaic acid C

C17H23N3O4 (333.1688)


   

SCHEMBL12427457

SCHEMBL12427457

C17H23N3O4 (333.1688)


   

anhydromarmeline

anhydromarmeline

C22H23NO2 (333.1729)


   
   
   
   
   
   
   
   
   
   
   
   
   
   

Tebufenpyrad

Pesticide4_Tebufenpyrad_C18H24ClN3O_1H-Pyrazole-5-carboxamide, 4-chloro-N-[[4-(1,1-dimethylethyl)phenyl]methyl]-3-ethyl-1-methyl-

C18H24ClN3O (333.1608)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

2-(4-HEXYLPHENYL)QUINOLINE-4-CARBOXYLICACID

2-(4-HEXYLPHENYL)QUINOLINE-4-CARBOXYLICACID

C22H23NO2 (333.1729)


   

4-Cyanophenyl 4-trans-(4-ethylcyclohexyl)benzoate

4-Cyanophenyl 4-trans-(4-ethylcyclohexyl)benzoate

C22H23NO2 (333.1729)


   

[6-(2-methylbutan-2-yl)pyridin-2-yl]-diphenylphosphane

[6-(2-methylbutan-2-yl)pyridin-2-yl]-diphenylphosphane

C22H24NP (333.1646)


   

TERT-BUTYL 7-AMINO-4-OXO-3,4-DIHYDROSPIRO[BENZO[E][1,3]OXAZINE-2,4-PIPERIDINE]-1-CARBOXYLATE

TERT-BUTYL 7-AMINO-4-OXO-3,4-DIHYDROSPIRO[BENZO[E][1,3]OXAZINE-2,4-PIPERIDINE]-1-CARBOXYLATE

C17H23N3O4 (333.1688)


   

Sibutramine hydrochloride monohydrate

Sibutramine hydrochloride monohydrate

C17H29Cl2NO (333.1626)


D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants C78272 - Agent Affecting Nervous System > C29728 - Anorexiant

   

Enpromate

Enpromate

C22H23NO2 (333.1729)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

Boc-HomoArg(NO2)-OH

Boc-HomoArg(NO2)-OH

C12H23N5O6 (333.1648)


   

3-Chloro-4-(1-piperidin-4-ylmethyl-piperidin-4-yloxy)benzonitrile

3-Chloro-4-(1-piperidin-4-ylmethyl-piperidin-4-yloxy)benzonitrile

C18H24ClN3O (333.1608)


   

2-Chloro-4-(1-piperidin-4-ylmethyl-piperidin-4-yloxy)benzonitrile

2-Chloro-4-(1-piperidin-4-ylmethyl-piperidin-4-yloxy)benzonitrile

C18H24ClN3O (333.1608)


   
   

trans-4-Cyano[1,1-biphenyl]-4-yl 4-ethylcyclohexanecarboxylate

trans-4-Cyano[1,1-biphenyl]-4-yl 4-ethylcyclohexanecarboxylate

C22H23NO2 (333.1729)


   

3-nitro-2,6-di(piperidin-1-yl)benzoic acid

3-nitro-2,6-di(piperidin-1-yl)benzoic acid

C17H23N3O4 (333.1688)


   

L-Prolyl-L-phenylalanyl-L-alanine

L-Prolyl-L-phenylalanyl-L-alanine

C17H23N3O4 (333.1688)


   
   

3,4-Bis(benzyloxy)phenethylamine hydrochloride

3,4-Bis(benzyloxy)phenethylamine hydrochloride

C22H23NO2 (333.1729)


   

H-Ala-Pro-Phe-OH

H-Ala-Pro-Phe-OH

C17H23N3O4 (333.1688)


   

Phe-Ala-Pro

Phe-Ala-Pro

C17H23N3O4 (333.1688)


A tripeptide composed of L-phenylalanine, L-alanine and L-proline joined in sequence by peptide linkages.

   

Benzoxazolium, 3-ethyl-2-(3-(3-ethyl-2(3H)-benzoxazolylidene)-1-propenyl)-

Benzoxazolium, 3-ethyl-2-(3-(3-ethyl-2(3H)-benzoxazolylidene)-1-propenyl)-

C21H21N2O2+ (333.1603)


D004396 - Coloring Agents > D002232 - Carbocyanines

   

Phenylalanyl-prolyl-alanine

Phenylalanyl-prolyl-alanine

C17H23N3O4 (333.1688)


   

(alphaS,betaS)-alpha-Ethyl-alpha-(4-methoxyphenyl)-beta-phenyl-2-pyridineethanol

(alphaS,betaS)-alpha-Ethyl-alpha-(4-methoxyphenyl)-beta-phenyl-2-pyridineethanol

C22H23NO2 (333.1729)


   

L-prolyl-L-phenyl-L-alanine

L-prolyl-L-phenyl-L-alanine

C17H23N3O4 (333.1688)


   

4-Hydroxyoctanedioylcarnitine

4-Hydroxyoctanedioylcarnitine

C15H27NO7 (333.1787)


   

3-Hydroxyoctanedioylcarnitine

3-Hydroxyoctanedioylcarnitine

C15H27NO7 (333.1787)


   

6-(2-Hydroxyethoxy)-6-oxohexanoylcarnitine

6-(2-Hydroxyethoxy)-6-oxohexanoylcarnitine

C15H27NO7 (333.1787)


   

C3-oxacyanine cation

C3-oxacyanine cation

C21H21N2O2+ (333.1603)


   

4-(1H-benzimidazol-2-ylmethylamino)-1,5-dimethyl-2-phenyl-3-pyrazolone

4-(1H-benzimidazol-2-ylmethylamino)-1,5-dimethyl-2-phenyl-3-pyrazolone

C19H19N5O (333.159)


   

3-(2-methoxyethyl)-2,4-dioxo-N-pentyl-1H-quinazoline-7-carboxamide

3-(2-methoxyethyl)-2,4-dioxo-N-pentyl-1H-quinazoline-7-carboxamide

C17H23N3O4 (333.1688)


   

1,3-Dimethyl-5-[[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanyl)amino]methylidene]-1,3-diazinane-2,4,6-trione

1,3-Dimethyl-5-[[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanyl)amino]methylidene]-1,3-diazinane-2,4,6-trione

C17H23N3O4 (333.1688)


   

Spectinomycin(1+)

Spectinomycin(1+)

C14H25N2O7+ (333.1662)


A secondary ammonium ion derived from spectinomycin by protonation of the secondary amino group located between the two alcoholic hydroxy groups.

   
   
   
   
   
   

N-(6-acetyl-1,3-benzodioxol-5-yl)-2-(4-ethyl-1-piperazinyl)acetamide

N-(6-acetyl-1,3-benzodioxol-5-yl)-2-(4-ethyl-1-piperazinyl)acetamide

C17H23N3O4 (333.1688)


   

N-[(1S)-2-hydroxy-1-phenylethyl]-N-(3-methylbut-2-enyl)-3-phenyl-2-propynamide

N-[(1S)-2-hydroxy-1-phenylethyl]-N-(3-methylbut-2-enyl)-3-phenyl-2-propynamide

C22H23NO2 (333.1729)


   

3-Ethyl-2-[3-(3-ethyl-1,3-benzoxazol-3-ium-2-yl)prop-2-enylidene]-1,3-benzoxazole

3-Ethyl-2-[3-(3-ethyl-1,3-benzoxazol-3-ium-2-yl)prop-2-enylidene]-1,3-benzoxazole

C21H21N2O2+ (333.1603)


   

4-Hydroxy-5-heptyl-6H-pyrido[3,2,1-jk]carbazole-6-one

4-Hydroxy-5-heptyl-6H-pyrido[3,2,1-jk]carbazole-6-one

C22H23NO2 (333.1729)


   
   
   
   
   
   
   

L-Leucyl-L-methionyl-L-alanine

L-Leucyl-L-methionyl-L-alanine

C14H27N3O4S (333.1722)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

2-[(2E)-2-[[4-(dimethylamino)phenyl]methylidene]hydrazinyl]-4-phenyl-1H-pyrimidin-6-one

2-[(2E)-2-[[4-(dimethylamino)phenyl]methylidene]hydrazinyl]-4-phenyl-1H-pyrimidin-6-one

C19H19N5O (333.159)


   

4-(3-Acetyloxy-2-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Acetyloxy-2-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C15H27NO7 (333.1787)


   
   
   
   
   

(1s,10s,13s)-13-(hydroxymethyl)-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-2,4,6,8(15),11-pentaene-1,2,11-triol

(1s,10s,13s)-13-(hydroxymethyl)-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-2,4,6,8(15),11-pentaene-1,2,11-triol

C17H23N3O4 (333.1688)


   

(e,2e)-n-[(1e)-2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethenyl]-3-phenylprop-2-enimidic acid

(e,2e)-n-[(1e)-2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethenyl]-3-phenylprop-2-enimidic acid

C22H23NO2 (333.1729)


   

n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethenyl)-3-phenylprop-2-enimidic acid

n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethenyl)-3-phenylprop-2-enimidic acid

C22H23NO2 (333.1729)


   

(1r,10s,13s)-13-(hydroxymethyl)-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-2,4,6,8(15),11-pentaene-1,2,11-triol

(1r,10s,13s)-13-(hydroxymethyl)-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-2,4,6,8(15),11-pentaene-1,2,11-triol

C17H23N3O4 (333.1688)


   

13-(hydroxymethyl)-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-2,4,6,8(15),11-pentaene-1,2,11-triol

13-(hydroxymethyl)-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-2,4,6,8(15),11-pentaene-1,2,11-triol

C17H23N3O4 (333.1688)


   

(3s,11as,11bs)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

(3s,11as,11bs)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

C17H23N3O4 (333.1688)


   

5-(3-amino-3-carboxypropyl)-1h,2h,3h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

5-(3-amino-3-carboxypropyl)-1h,2h,3h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

C17H23N3O4 (333.1688)


   

(3s,11ar,11br)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

(3s,11ar,11br)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

C17H23N3O4 (333.1688)